Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Stimulated CD4+ T lymphocytes can differentiate into effector T cell (Teff) or inducible regulatory T cell (Treg) subsets with specific immunological roles. We show that Teff and Treg require distinct metabolic programs to support these functions. Th1, Th2, and Th17 cells expressed high surface levels of the glucose transporter Glut1 and were highly glycolytic. Treg, in contrast, expressed low levels of Glut1 and had high lipid oxidation rates. Consistent with glycolysis and lipid oxidation promoting Teff and Treg, respectively, Teff were selectively increased in Glut1 transgenic mice and reliant on glucose metabolism, whereas Treg had activated AMP-activated protein kinase and were dependent on lipid oxidation. Importantly, AMP-activated protein kinase stimulation was sufficient to decrease Glut1 and increase Treg generation in an asthma model. These data demonstrate that CD4+ T cell subsets require distinct metabolic programs that can be manipulated in vivo to control Treg and Teff development in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to Treg cells, TH2 cells were shown to display an increased glycolytic rate44.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“This increased mitochondrial metabolism in Tregs was found to be due to increased AMPK-dependent fatty acid oxidation (MacIver et al., 2011; Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Different subsets of T cells, as well as different stages following T cell activation, are characterized by the use of different metabolic pathways [97, 108, 109].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [108]
In the citing paper
“Tregs have elevated levels of oxidative phosphorylation and decreased glycolytic flux compared to Th17 cells (Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
In the citing paper
“This was first demonstrated by Michalek et al. (34), who determined that proinflammatory CD4+ T helper (TH) cells (TH1, TH2, and TH17 lineages) displayed a strong bias toward glycolysis over mitochondrial metabolism, whereas induced CD4+ T regulatory (Treg) lineage cells displayed a mixed metabolism involving glycolysis, lipid oxidation, and OXPHOS.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“To meet these requirements, activated T cells decrease lipid oxidation and undergo a rapid increase in glycolysis (4).”
BackgroundmTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · cited 2×
“At the conclusion of an immune response, decreased glycolysis and increased lipid oxidation can favor the enrichment of long-lived CD8 memory cells (5, 6).”
BackgroundEnhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 4×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodInfluentialThe mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Jacobs, S. R., Herman, C. E., MacIver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., & Rathmell, J. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4476 · Cited by 850 · cited 5×
“1G) and Ig deposition in the kidneys (3).”
BackgroundSelf-citationAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813 · cited 1×
“In contrast, the AMPK pathway acts to inhibit mTOR by suppressing mTOR signaling and to promote mitochondrial oxidative metabolism rather than glycolysis (10).”
BackgroundThe AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Haxhinasto, S., Mathis, D., & Benoist, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071477 · Cited by 737 · cited 1×
“Inhibition of mTOR can result in the elevated oxidation of exogenous FA (15) and promote Treg differentiation (16).”
BackgroundStability of the Regulatory T Cell Lineage in Vivo
Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., & Rudensky, A. Y. (2010) · Science · doi:10.1126/science.1191996 · Cited by 730 · cited 1×
“stable pool of important immune regulatory cells (18), and lipid oxidation may be central in contributing to their maintenance and self-renewal.”
BackgroundWieman, H. L., Wofford, J. A., & Rathmell, J. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0593 · Cited by 593 · cited 3×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodSelf-citation
Cited by
Items 401–500 of 1,005
Immunometabolism in Tuberculosis
Shi, L., Eugenín, E. A., & Subbian, S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00150 · Cited by 121
Coenzyme A fuels T cell anti-tumor immunity
Paul, M. S., Saibil, S. D., Han, S., Israni-Winger, K., Lien, S. C., Laister, R. C., Sayad, A., Penny, S. L., Amaria, R. N., Haydu, L. E., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.11.010 · Cited by 118
MYC in Regulating Immunity: Metabolism and Beyond
Gnanaprakasam, J. R., & Wang, R. (2017) · Genes · doi:10.3390/genes8030088 · Cited by 124
“T helper type 17 (TH17) cells and induced regulatory T (iTreg) cells, two closely related subsets [113–115], differentially utilize glucose and fatty acids as their primary fuels, respectively [86,94,116].”
BackgroundRashida Gnanaprakasam, J. N., Wu, R., & Wang, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01075 · Cited by 107
“While glycolysis and FAO primarily provide the OXPHOX substrate, acetyl-CoA, for mitochondria in Tnai cells, Tmem cells, and Treg cells (14, 15, 18, 19), heightened mitochondrial biogenesis during T cell activation leads to higher numbers of mitochondria and likely the enhanced mitochondrial dependent metabolic flux i…”
BackgroundKim, D., Nguyen, Q. T., Lee, J., Lee, S. H., Janocha, A. J., Kim, S., Le, H. T., Dvorina, N., Weiss, K., Cameron, M. J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.002 · Cited by 299
GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency
Guerrero, J. A., Klysz, D. D., Chen, Y., Malipatlolla, M. B., Lone, J. B., Fowler, C., Stuani, L., May, A., Bashti, M., Xu, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52666-y · Cited by 132
“Although novel, this fi nding aligns with previous evidence that aerobic glycolysis is indispensable for Th 17 differentiation 48,49 , and GLUT1 expression is elevated in Th 17 T cells 3 .”
BackgroundFrom tumor cell metabolism to tumor immune escape
Villalba, M., Rathore, M. G., López-Royuela, N., Krzywińska, E., Garaude, J., & Allende-Vega, N. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.04.024 · Cited by 119
“Interestingly, regulatory T cells (Treg) do not appear to be affected by the presence of lactate or an acidic microenvironment, because their metabolism relies on fatty acid oxidation (Michalek et al., 2011).”
BackgroundActivation of Mevalonate Pathway Via LKB1 is Essential for Stability of Treg Cells
Timilshina, M., You, Z., Lacher, S. M., Acharya, S., Jiang, L., Kang, Y., Kim, J., Chang, H. W., Kim, K., Park, B., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.020 · Cited by 113
Mitochondrial phenotypes in purified human immune cell subtypes and cell mixtures
Rausser, S., Trumpff, C., McGill, M. A., Junker, A., Wang, W., Ho, S.-H., Mitchell, A., Karan, K. R., Monk, C., Segerstrom, S. C., et al. (2021) · eLife · doi:10.7554/elife.70899 · Cited by 102
Lactylated Apolipoprotein C‐II Induces Immunotherapy Resistance by Promoting Extracellular Lipolysis
Chen, J., Zhao, D., Wang, Y., Liu, M., Zhang, Y., Feng, T., Xiao, C., Huan, S., Miao, R., Xu, L. N., et al. (2024) · Advanced Science · doi:10.1002/advs.202406333 · Cited by 153
Shi, Y., Zhang, H., & Miao, C. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02403-1 · Cited by 131
Vitamin D endocrinology on the cross-road between immunity and metabolism
Vanherwegen, A.-S., Gysemans, C. A., & Mathieu, C. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.04.018 · Cited by 117
Clerc, I., Moussa, D. A., Vahlas, Z., Tardito, S., Oburoglu, L., Hope, T. J., Sitbon, M., Dardalhon, V., Mongellaz, C., & Taylor, N. N. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0084-1 · Cited by 121
Qorraj, M., Bruns, H., Böttcher, M., Weigand, L., Saul, D., Mackensen, A., Jitschin, R., & Mougiakakos, D. (2016) · Leukemia · doi:10.1038/leu.2016.214 · Cited by 112
Obesity altered T cell metabolism and the response to infection
Green, W. D., & Beck, M. A. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.03.008 · Cited by 104
“Importantly, this glycolytic shift supports effector functions, which varies depending on T cell subtype [3,11,16].”
BackgroundTao, J.-H., Barbi, J. J., & Pan, F. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00204.2015 · Cited by 112
Bettencourt, I. A., & Powell, J. D. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601318 · Cited by 103
“The alternatively activated M2 macrophages have a metabolism somewhat similar to Tregs with oxidative phosphorylation providing their energy, as opposed to aerobic glycolysis (39).”
BackgroundInfluentialMetabolic reprogramming during the Trypanosoma brucei life cycle
Smith, T., Bringaud, F., Nolan, D. P., & Figueiredo, L. M. (2017) · F1000Research · doi:10.12688/f1000research.10342.1 · Cited by 105
Kumar, V. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.05.001 · Cited by 122
Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications
Fearon, U., Hanlon, M. M., Floudas, A., & Veale, D. J. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00771-x · Cited by 118
Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity
Townsend, K. N., Hughson, L. R. K., Schlie, K., Poon, V. I., Westerback, A., & Lum, J. J. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01141.x · Cited by 102
“Inhibits Lck signaling in T cells (97), thus decreases T cell receptor activation and induction of glycolysis (106-108) Treg cells do not rely as heavily on glycolysis therefore they may not be as affected by imatinib treatment (109, 110).”
BackgroundRocca, C. L., Carbone, F., Rosa, V. D., Colamatteo, A., Galgani, M., Perna, F., Lanzillo, R., Morra, V. B., Orefice, G., Cerillo, I., et al. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.011 · Cited by 107
Lu, Y., Li, Y., Liu, Q. F., Du, P., Du, P., Zhu, F., Han, Y., Liu, X., Liu, X., Wang, X., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.041 · Cited by 107
Metabolic reprograming of anti-tumor immunity
Sukumar, M., Kishton, R. J., & Restifo, N. P. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.03.011 · Cited by 101
Very‐low‐carbohydrate diet enhances human T‐cell immunity through immunometabolic reprogramming
Hirschberger, S., Strauß, G., Effinger, D., Marstaller, X., Ferstl, A., Müller, M. B., Wu, T., Hübner, M., Rahmel, T., Mascolo, H., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114323 · Cited by 108
“Activated T cells obtain a large proportion of their ATP production through aerobic glycolysis both in vitro and in vivo (Michalek et al, 2011; Chang et al, 2013; Macintyre et al, 2014; Buck et al, 2016).”
BackgroundmTOR and lymphocyte metabolism
Zeng, H., & Chi, H. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.05.002 · Cited by 104
mTORC1 signaling and IL‐17 expression: Defining pathways and possible therapeutic targets
Ren, W., Yin, J., Duan, J., Liu, G., Tan, B., Yang, G., Wu, G., Bazer, F. W., Peng, Y., & Yin, Y. (2015) · European Journal of Immunology · doi:10.1002/eji.201545886 · Cited by 105
T Cells and Cancer: How Metabolism Shapes Immunity
Molon, B., Calì, B., & Viola, A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00020 · Cited by 99
Targeting T Cell Activation and Lupus Autoimmune Phenotypes by Inhibiting Glucose Transporters
Li, W., Qu, G., Choi, S.-C., Cornaby, C., Titov, A., Kanda, N., Teng, X., Wang, H., & Morel, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00833 · Cited by 100
The metabolism-modulating activity of IL-17 signaling in health and disease
Bechara, R., McGeachy, M. J., & Gaffen, S. L. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202191 · Cited by 105
Jin, Y., Wang, Z., He, D., Zhu, Y., Chen, X., & Cao, K. (2021) · Cancer Medicine · doi:10.1002/cam4.4341 · Cited by 107
Deacetylation by SIRT1 Reprograms Inflammation and Cancer
Liu, T. F., & McCall, C. E. (2013) · Genes & Cancer · doi:10.1177/1947601913476948 · Cited by 111
“Finally, SIRT1 not only regulated acute inflammation by modifying chromatin and extranuclear proteins, but it also integrates metabolism with the acute inflammatory process by supporting a metabolic switch during adaptation.(4,5,87) In the initiation phase, TLR activation rapidly increases glucose flux to meet the ene…”
BackgroundInteractions between adipose tissue and the immune system in health and malnutrition
Wensveen, F. M., Marinović, S., Šestan, M., Wensveen, T. T., & Polić, B. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.10.006 · Cited by 110
The obesity-related pathology and Th17 cells
Endo, Y., Yokote, K., & Nakayama, T. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2399-3 · Cited by 105
“In accordance with these observations, Treg cells predominantly use OXPHOS and mitochondrial fatty acid oxidation (FAO) for their development and survival [94], whereas the differentiation of Th17 cells strongly requires glycolysis, similar to Th1 and Th2 cells [69, 81, 95].”
BackgroundHypoxia-inducible factors regulate T cell metabolism and function
Phan, A. T., & Goldrath, A. W. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.08.004 · Cited by 106
Metabolic Stress in the Immune Function of T Cells, Macrophages and Dendritic Cells
Domblides, C., Lartigue, L., & Faustin, B. (2018) · Cells · doi:10.3390/cells7070068 · Cited by 97
“In mice models, TRegs have shown high levels of AMPK and stimulation of AMPK leads to decreased GLUT-1 expression [16].”
BackgroundInfluentialKetelhuth, D. F. J., Lutgens, E., Bäck, M., Binder, C. J., den Bossche, J. V., Daniel, C., Dumitriu, I. E., Hoefer, I. E., Libby, P., O'Neill, L. A. J., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz166 · Cited by 106
“Inhibition of glycolysis with 2-deoxyglucose (2DG) shifts the polarization of naı̈ve T cells from Th17 towards Tregs.42 Hence, increased OXPHOS metabolism has been linked to the induction Tregs.43 Interestingly, the glycolytic enzyme enolase has been shown to promote Foxp3 splicing and the generation of Treg cells thr…”
BackgroundInfluentialCD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation
Beckermann, K. E., Hongo, R. A., Ye, X., Young, K. L., Carbonell, K., Contreras, D. C., Siska, P. J., Barone, S. M., Roe, C. E., Smith, C. C., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138729 · Cited by 109
Self-citationEGCG Attenuates Autoimmune Arthritis by Inhibition of STAT3 and HIF-1α with Th17/Treg Control
Yang, E., Lee, J. J., Lee, S.-Y., Kim, E., Moon, Y., Jung, Y. O., Park, S., & Cho, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086062 · Cited by 98
“It was recently suggested that this is a metabolic check point for the differentiation of Th17 and Treg cells [14].”
BackgroundGut microbiota and mTOR signaling: Insight on a new pathophysiological interaction
Noureldein, M. H., & Eid, A. A. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.03.021 · Cited by 102
Regulation of Immune Cell Functions by Metabolic Reprogramming
Kim, J. (2018) · Journal of Immunology Research · doi:10.1155/2018/8605471 · Cited by 108
“When the antigenic stimuli are eliminated, most TEFF cells die, leaving behind a small antigen-specific T cell population that becomes memory T cells (Tm).”
InfluentialThe Intercellular Metabolic Interplay between Tumor and Immune Cells
Wang, T., Liu, G., & Wang, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00358 · Cited by 97
Cretenet, G., Clerc, I., Matias, M. I., Loisel‐Meyer, S., Craveiro, M., Oburoglu, L., Kinet, S., Mongellaz, C., Dardalhon, V., & Taylor, N. N. (2016) · Scientific Reports · doi:10.1038/srep24129 · Cited by 105
Metabolic regulation of immune responses: therapeutic opportunities
Assmann, N., & Finlay, D. K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83005 · Cited by 97
“In mice, Foxp3– type 1 regulatory cells have high levels of glycolysis similar to effector T cells (88, 89).”
mTOR, linking metabolism and immunity
Xu, X., Ye, L., Araki, K., & Ahmed, R. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.005 · Cited by 96
“It has been postulated that Treg differentiation depends more on fatty acid oxidation and mitochondrial respiration as an energy source, whereas effector T cells display highly glycolytic metabolic demand [30, 32].”
BackgroundA Stat6/Pten Axis Links Regulatory T Cells with Adipose Tissue Function
Kälin, S., Becker, M., Ott, V. B., Serr, I., Hosp, F., Mollah, M. M. H., Keipert, S., Lamp, D., Rohner-Jeanrenaud, F., Flynn, V. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.008 · Cited by 95
Interleukin-7: Fuel for the autoimmune attack
Dooms, H. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.007 · Cited by 102
Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems
Ross, T. T., Crowley, C., Kelly, K. L., Rinaldi, A., Beebe, D. A., Lech, M. P., Martinez, R. V., Carvajal-Gonzalez, S., Boucher, M., Hirenallur-Shanthappa, D., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.06.001 · Cited by 94
“phosphate-activated protein kinase, which suppresses lipogenesis, opposes mammalian target of rapamycin, promotes fatty acid oxidation rather than glycolysis, and promotes polarization to the anti-inflammatory Treg cells.(28) Berod et al(10) showed that inhibition of DNL flux by suppression of ACC activity blocks pola…”
BackgroundNutrient and Metabolic Sensing in T Cell Responses
Wei, J., Raynor, J., Nguyen, T.-L. M., & Chi, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00247 · Cited by 94
Ushio‐Fukai, M., Ash, D., Nagarkoti, S., de Chantemèle, E. J. B., Fulton, D. J., & Fukai, T. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8161 · Cited by 102
“Moreover, regulatory T cells (Tregs) activate AMPK and depend on lipid oxidation for their energy requirements (237, 257, 303, 351).”
Revilla, S. A., Kranenburg, O., & Coffer, P. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.903564 · Cited by 116
“FOXP3 also influences LDH activity, promoting the conversion of lactate to pyruvate and increasing oxidative phosphorylation (OXPHOS), and the NAD : NADH ratio.”
BackgroundInfluentialWu, H., Huang, H., & Zhao, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1211221 · Cited by 126
Nutrients: Signal 4 in T cell immunity
Raynor, J. L., & Chi, H. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20221839 · Cited by 110
“Th1, Th2, and Th17 cells are highly glycolytic compared with in vitro inducible Treg (iTreg) cells, and glycolysis is essential to promote Th1 and Th17 cell generation (Gerriets et al., 2015; Michalek et al., 2011; Shi et al., 2011).”
BackgroundXie, D., Zhu, S., & Bai, L. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-0348-7 · Cited by 103
“Interestingly, Tregs and memory CD8 T cells utilize oxidative phosphorylation for energy generation.”
BackgroundWilliamson, M. K., Coombes, N. S., Juszczak, F., Athanasopoulos, M., Khan, M. M., Eykyn, T. R., Srenathan, U., Taams, L. S., Zeidler, J. D., Poian, A. T. D., et al. (2018) · Viruses · doi:10.3390/v10030114 · Cited by 103
“GLUT1 overexpression in a transgenic mouse model increased the expression of cytokines by effector T cells (Teff) and the incidence of inflammatory events [27,30].”
BackgroundZhang, M., Zhou, L., Wang, Y., Dorfman, R. G., Tang, D., Xu, L., Pan, Y., Zhou, Q., Li, Y., Yin, Y., et al. (2019) · International Immunology · doi:10.1093/intimm/dxz022 · Cited by 93
Future prospects for CD8+ regulatory T cells in immune tolerance
Flippe, L., Bézie, S., Anegón, I., & Guillonneau, C. (2019) · Immunological Reviews · doi:10.1111/imr.12812 · Cited by 110
The Mucosal Immune System and Its Regulation by Autophagy
Kabat, A. M., Pott, J., & Maloy, K. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00240 · Cited by 92
“As CD4+ T cells begin to proliferate and differentiate, metabolic programs support the commitment into separate lineages, with major roles for mTOR and AMPK in tailoring the metabolic adaptations of particular CD4+ T cell subsets (228, 229).”
BackgroundPolarizing Macrophages through Reprogramming of Glucose Metabolism
Blagih, J., & Jones, R. G. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.008 · Cited by 108
“Recent evidence suggests that immune cells adopt specific metabolic signatures required for proper effector function (Michalek et al., 2011).”
BackgroundLkb1 maintains Treg cell lineage identity
Wu, D., Luo, Y., Guo, W., Niu, Q., Xue, T., Yang, F., Sun, X., Chen, S., Liu, Y., Liu, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15876 · Cited by 92
The m TOR pathway and integrating immune regulation
Cobbold, S. P. (2013) · Immunology · doi:10.1111/imm.12162 · Cited by 107
CD39 and CD161 Modulate Th17 Responses in Crohn's Disease
Bai, A., Moss, A. C., Kokkotou, E. G., Usheva, A., Sun, X., Cheifetz, A. S., Zheng, Y., Longhi, M. S., Gao, W., Wu, Y., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400346 · Cited by 97
“These data suggest that CD39CD161 Th17 cells are preferentially active metabolically with respect to glycolytic pathways (32, 33).”
BackgroundProgrammed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality
Saha, A., O’Connor, R. S., Thangavelu, G., Lovitch, S. B., Dandamudi, D. B., Wilson, C. B., Vincent, B. G., Tkachev, V., Pawlicki, J. M., Furlan, S. N., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85796 · Cited by 98
“To fulfill the bioenergetic and biosynthetic demands of proliferation, migration and cytolysis, T-cells reprogram their metabolic pathways for a number of substrates including glucose (37, 38), glutamine (39, 40) and fatty acids (FAs) (41, 42).”
BackgroundClinical significance of T cell metabolic reprogramming in cancer
Herbel, C., Patsoukis, N., Bardhan, K., Seth, P., Weaver, J. D., & Boussiotis, V. A. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0110-9 · Cited by 102
“Glycolysis has a key role on the T cell fate upon antigenencounter and is mandatory for the differentiation of the naïve T cells into antigen-specific T effectors (TEFF) [7, 18, 19].”
BackgroundInfluentialEpigenetics and Immunometabolism in Diabetes and Aging
Guzik, T. J., & Cosentino, F. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7299 · Cited by 91
“T regulatory cells (Treg) are, in turn, dependent on oxidative phosphorylation and lipid peroxidation (93, 101).”
BackgroundGardiner, C. M. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0718-260r · Cited by 102
Dimeloe, S., Gubser, P., Loeliger, J., Frick, C., Develioglu, L., Fischer, M., Marquardsen, F., Bantug, G. R., Thommen, D., Lecoultre, Y., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aav3334 · Cited by 91
Keeping the immune system in check: a role for mitophagy
Lazarou, M. (2015) · Immunology & Cell Biology · doi:10.1038/icb.2014.75 · Cited by 91
Cerebral gluconeogenesis and diseases
Yip, J., Geng, X., Shen, J., & Ding, Y. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00521 · Cited by 89
“In tumors, however, the cytotoxic functions of TIL such as IFN-γ, IL-2, IL-17, and granzyme B production are inhibited by multiple environmental factors (Cham et al., 2008; Mellman et al., 2011; Michalek et al., 2011; Shiao et al., 2011; Finlay et al., 2012; Chang et al., 2013).”
BackgroundMetformin and its anti-inflammatory and anti-oxidative effects; new concepts
Dehkordi, A. H., Abbaszadeh, A., Mir, S., & Hasanvand, A. (2018) · Journal of Renal Injury Prevention · doi:10.15171/jrip.2019.11 · Cited by 105
“Signaling mTOR and its downstream genes are involved in inducing these metabolic pathways, while Treg cells obtain their energy through lipid oxidation (47,48).”
BackgroundKoga, T., Sato, T., Furukawa, K., Morimoto, S., Endo, Y., Umeda, M., Sumiyoshi, R., Fukui, S., Kawashiri, S., Iwamoto, N., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40785 · Cited by 94
Solute carriers (SLCs) in cancer
El-Gebali, S., Bentz, S., Hediger, M. A., & Anderle, P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.007 · Cited by 96
mTOR Signaling in T Cell Immunity and Autoimmunity
Liu, Y., Zhang, D., & Liu, X. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.933957 · Cited by 97
“Treg differentiation depends more on fatty acid oxidation and mitochondrial respiration as energy sources, while effector T cells display more glycolytic metabolic demands [83, 84].”
BackgroundLoss of ABCG1 influences regulatory T cell differentiation and atherosclerosis
Cheng, H., Gaddis, D. E., Wu, R., McSkimming, C. C., Haynes, L. D., Taylor, A. M., McNamara, C. A., Sorci‐Thomas, M. G., & Hedrick, C. C. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83136 · Cited by 96
“For example, the differentiation of Th1, Th2, and Th17 Teffs requires high mTOR activation, while Treg differentiation shows the opposite (26, 27).”
BackgroundHomeostasis and transitional activation of regulatory T cells require c-Myc
Saravia, J., Zeng, H., Dhungana, Y., Blanco, D. B., Nguyen, T.-L. M., Chapman, N. M., Wang, Y., Kanneganti, A., Liu, S., Raynor, J. L., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaw6443 · Cited by 90
Rivera Vargas, T., Cai, Z., Shen, Y., Dosset, M., Benoit-Lizon, I., Martin, T., Roussey, A., Flavell, R. A., Ghiringhelli, F., & Apetoh, L. (2017) · Nature Communications · doi:10.1038/s41467-017-00468-w · Cited by 87
Immunological contributions to adipose tissue homeostasis
DiSpirito, J. R., & Mathis, D. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.10.005 · Cited by 88
“Given recent findings on the preference of fatty acids (FA) as a fuel source for certain anti-inflammatory immunocytes, including Tregs and anti-inflammatory macrophages [48,49], it is interesting to consider whether these AT-resident immunocytes may secrete lipolytic cytokines to increase the local concentration of F…”
Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells
Wang, Y., Huang, G., Zeng, H., Yang, K., Lamb, R. F., & Chi, H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308905110 · Cited by 88
“Proc Natl Acad Sci USA 109(6):E343–E352.”
Fatty acid synthase regulates the pathogenicity of Th17 cells
Marks, K. E., Flaherty, S., Woodman, K., Sharma-Walia, N., & Reynolds, J. M. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ab0417-159rr · Cited by 91
Kim, S., Jang, J.-Y., Koh, J., Kwon, D., Kim, Y. A., Paeng, J. C., Ock, C., Keam, B., Kim, M., Kim, T. M., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1407-5 · Cited by 94
Mockler, M. B., Conroy, M. J., & Lysaght, J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00107 · Cited by 88
Activated lymphocytes as a metabolic model for carcinogenesis
Macintyre, A. N., & Rathmell, J. C. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-5 · Cited by 88
“Indeed, even once T cell functional and metabolic fate has been defined there is a degree of reversibility and plasticity, for example, lipid-dependent regulatory T cells can be redirected to form highly glycolytic, IL-17-producing cells by altering the cytokine environment [41,135].”
BackgroundInfluentialSelf-citationImmunologic impact of the intestine in metabolic disease
Winer, D. A., Winer, S., Dranse, H. J., & Lam, T. K. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88879 · Cited by 86
Metabolic control of regulatory T cell stability and function by TRAF3IP3 at the lysosome
Yu, X., Teng, X.-L., Wang, F., Zheng, Y., Qu, G., Zhou, Y., Hu, Z., Wu, Z., Chang, Y., Chen, L., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180397 · Cited by 86
“Unlike CD4+ effector T cells, T reg cells rely on oxidative phosphorylation (OXP HOS) rather than glycolysis for the energy needed to support their expansion, survival, and function (Michalek et al., 2011; Coe et al., 2014; Newton et al., 2016).”
Resident-Memory T Cells in Tissue-Restricted Immune Responses: For Better or Worse?
Steinbach, K., Vincenti, I., & Merkler, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02827 · Cited by 98
Pokhrel, R. H., Acharya, S., Ahn, J.-H., Gu, Y., Pandit, M., Kim, J., Park, Y., Kang, B., Ko, H., & Chang, J. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01420-9 · Cited by 99
“However, Tregs mainly depend on FAO to survive and function [4, 35].”
The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases
Cao, H., Diao, J., Liu, H., Liu, S., Liu, J., Yuan, J., & Lin, J. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac199 · Cited by 95
Lactate and Lactylation: Dual Regulators of T-Cell-Mediated Tumor Immunity and Immunotherapy
Hao, Z.-N., Tan, X.-P., Zhang, Q., Li, J., Xia, R., & Ma, Z. (2024) · Biomolecules · doi:10.3390/biom14121646 · Cited by 100
“Unlike effector T cells, Tregs exhibit a greater metabolic reliance on fatty acid oxidation (FAO) and OXPHOS, especially in glucose-deficient environments such as the TME or inflamed tissues [29].”
LKB 1 and AMPK: central regulators of lymphocyte metabolism and function
Blagih, J., Krawczyk, C. M., & Jones, R. G. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01157.x · Cited by 87
“Interestingly, CD4 T-cell activation in the absence of mTOR leads to the development of Tregs rather than Th effector cells (10), and treatment of mice with metformin, which leads to AMPK-dependent inhibition of mTOR, promotes Treg differentiation in vivo (120).”
BackgroundImmunometabolism in cancer at a glance
Singer, K., Cheng, W.-C., Kreutz, M. P., Ho, P., & Siska, P. J. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.034272 · Cited by 92
“Interestingly, as described in murine systems, Treg cells express low levels of Glut1, do not rely on glucose uptake and glycolysis, and, similarly to CD8+ memory T cells, perform OXPHOS and lipid oxidation (Michalek et al., 2011).”
Fuseini, H., Cephus, J.-Y., Wu, P., Davis, J. B., Contreras, D. C., Gandhi, V. D., Rathmell, J. C., & Newcomb, D. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02740 · Cited by 93
Self-citationPark, M.-J., Lee, S.-Y., Moon, S., Son, H., Lee, S., Kim, E., Byun, J. K., Shin, D. Y., Park, S., Yang, C. W., et al. (2016) · Translational research · doi:10.1016/j.trsl.2016.03.006 · Cited by 90
Powering the Immune System: Mitochondria in Immune Function and Deficiency
Walker, M. A., Volpi, S., Sims, K. B., Walter, J. E., & Traggiai, E. (2014) · Journal of Immunology Research · doi:10.1155/2014/164309 · Cited by 83
Changing the energy of an immune response.
Delmastro-Greenwood, M. M., & Piganelli, J. D. (2013) · Europe PMC (PubMed Central) · Cited by 106
Autophagy is critical for group 2 innate lymphoid cell metabolic homeostasis and effector function
Galle-Treger, L., Hurrell, B. P., Lewis, G. M., Howard, E. D., Shafiei-Jahani, P., Banie, H., Razani, B., Soroosh, P., & Akbari, O. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.10.035 · Cited by 89
Zhao, J., Jin, D., Huang, M., Ji, J., Xu, X., Wang, F., Zhou, L., Bao, B., Jiang, F., Xu, W., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1416472 · Cited by 84
Metabolic reprogramming in septic acute kidney injury: pathogenesis and therapeutic implications
Liu, C., Wei, W., Huang, Y., Fu, P., Zhang, L., & Zhao, Y. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155974 · Cited by 95
MYC and HIF in shaping immune response and immune metabolism
Gnanaprakasam, J. R., Sherman, J. W., & Wang, R. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.03.004 · Cited by 86
The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
Russell, B. L., Sooklal, S. A., Malindisa, S. T., Daka, L. J., & Ntwasa, M. M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.641428 · Cited by 86
Fighting in a wasteland: deleterious metabolites and antitumor immunity
Watson, M. J., & Delgoffe, G. M. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148549 · Cited by 86
Metadata
- Authors
- Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 186
- Issue
- 6
- Pages
- 3299-3303
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3198034
- OpenAlex
- W2157739158
- Cited by
- 2,091
- References
- 18
- Citations by year
- 2026: 116 · 2025: 133 · 2024: 168 · 2023: 163 · 2022: 214 · 2021: 215 · 2020: 209 · 2019: 167 · 2018: 147 · 2017: 164 · 2016: 122 · 2015: 88 · 2014: 69 · 2013: 55 · 2012: 47
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- Cancer Research Institute
- Lupus Research Institute
- Leukemia and Lymphoma Society
- American Asthma Foundation
- Lupus Research Alliance
- National Institutes of Health
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL108006)
- National Institute of Allergy and Infectious Diseases (R01AI063345)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- effector T cells, regulatory T cells, glycolysis, lipid oxidation, glucose transporter 1, AMPK, Th1 cells, Th2 cells, Th17 cells, asthma, Treg generation, inflammatory diseases
- MeSH terms
- Animals, Asthma, Cell Survival, Cells, Cultured, Disease Models, Animal, Glycolysis, T-Lymphocytes, Helper-Inducer, Mice, Inbred C57BL, Mice, Transgenic, Lipid Peroxidation, Immunophenotyping, T-Lymphocyte Subsets, T-Lymphocytes, Regulatory, Glucose Transporter Type 1, Mice, AMP-Activated Protein Kinases, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.